This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Adarx Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Sean Studer: Innovator in Prekallikrein Modulation
Introduction
Sean Studer is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the modulation of plasma prekallikrein (PKK). His innovative work has the potential to impact various therapeutic applications.
Latest Patents
Sean Studer holds a patent for "Prekallikrein-modulating compositions and methods of use thereof." This patent encompasses compounds, compositions, and methods designed to modulate the expression or activity of plasma prekallikrein. The disclosed methods can be utilized to reduce the expression of PKK mRNA and protein in cells or animals, showcasing the versatility and importance of his invention.
Career Highlights
Sean is currently associated with Adarx Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in the pharmaceutical industry, particularly in the realm of biomedicine.
Collaborations
Throughout his career, Sean has collaborated with talented individuals such as Zhen Li and Rui Zhu. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Sean Studer is a prominent figure in the field of biochemistry, with a focus on prekallikrein modulation. His patent and ongoing work at Adarx Pharmaceuticals, Inc. highlight his commitment to innovation and the advancement of medical science.